SlideShare una empresa de Scribd logo
1 de 52
Descargar para leer sin conexión
Primary Open angle Glaucoma
Dr. AR Rajalakshmi
• Glaucoma – Overview
• POAG clinical features
• Management
DEFINITION
• Glaucoma is a chronic, progressive optic
neuropathy caused by a group of ocular
conditions which lead to damage of the optic
nerve with loss of visual function.
• The most common risk factor known is a
raised intraocular pressure.
PATHOGENESIS
• MECHANICAL changes due to the rise of
intraocular pressure and
• VASCULAR perfusion of the optic nerve head.
MECHANICAL
mechanical pressure
on the lamina
cribrosa
mechanical pressure
on the lamina
cribrosa
altering capillary
blood flow
backward displacement
and compaction of the
laminar plates narrows
the openings through
which the axons pass
GANGLION CELL
DEATH
VASCULAR
rise in intraocular
pressure
mechanical
pressure on the
lamina cribrosa
decrease the
capillary blood
flow
mechanical
compression of
vessels at the
lamina cribrosa
GANGLION CELL
DEATH
Diagnosis
combination of clinical signs—characteristic
changes in
• the optic nerve head
• abnormalities in the visual field
• rise in intraocular pressure
• The type of glaucoma is determined by the
status of the anterior chamber angle as
determined by gonioscopy
Optic nerve head changes
OPTIC NERVE HEAD – EARLY SIGNS
Increase in vertical
c:d > 0.5
Asymmetry between the
two optic nerve heads of
more than 0.2
Baring of
circumlinear blood
vessel
Splinter
haemorrhages
Retinal nerve fibre layer defect
OPTIC NERVE HEAD – LATE CHANGES
MARKED CUPPING POLAR NOTCHING
Nasalisation of vessels
Peripapillary changes
Loss of NRR & disc pallor
VISUAL FIELD
• Portion of space in which objects are simultaneously
visible to the steadily fixating eye.
Visual field examination
Screening tests …
• Confrontational visual field testing
• Amsler grid (assesses the central 10° the
visual field ) .
Quantitative measurements using manual or
automated perimetry
DISTRIBUTION OF RETINAL NERVE FIBRES
BJERRUM’S AREA : an arcuate area extending
above and below the blind spot , 10 to 25 ̊
from fixation
Visual field defects
• Relative paracentral scotoma
• Roenne’s nasal step
• Seidel scotoma
• Arcuate scotoma
• Double arcuate / ring scotoma
• End stage / near total field defect
• RELATIVE PARACENTRAL
SCOTOMA – areas where
smaller / dimmer objects
are not visualised by patient
but larger & brighter objects
are seen
• SEIDEL SCOTOMA
• starts at the poles of the
blind spot , arches over the
macular area without
reaching the horizontal
meridian nasally
ARCUATE SCOTOMA
• Starts at superior or inferior
poles of blind spot
• Arches over macular area
• Ends as a horizontal line
nasally
• Does not cross the
horizontal divide of visual
field
DOUBLE ARCUATE / RING
SCOTOMA
• Two arcuate scotomas
expand to involve the
peripheral visual field
• Central(tubular vision ) and
temporal islands of vision
are left
ROENNE’S NASAL STEP
• Appearance of a horizontal
shelf in the nasal visual
field.
• Caused by asymmetrical
nerve fibre loss at the poles
END STAGE / NEAR TOTAL
FIELD DEFECT
• Small island of temporal
vision
Intraocular pressure
• IOP > 21mmHg on more
than one occasion
• Circadian Variation >
8mmHg
• Asymmetry in IOP
between 2 eyes of more
than 5 mmHg
GAT
Different types of tonometers
Gonioscopy
Grading of angles
van Herick
Shaffer system
Spaeth
Scheie
Schaffer’s grading
Grade 0
Grade 1
Grade 2
Grade 3
Grade 4
Grade 4 (35–45°) is the widest angle, the ciliary body can be visualized.
Grade 3 (25–35°) is an open angle, scleral spur is visible.
Grade 2 (20°) is an angle in which the trabeculum but not the scleral spur can be seen.
Grade 1 (10°) is a very narrow angle in which only the Schwalbe line and perhaps the top
of the trabeculum can be identified.
Slit angle is one in which there is no obvious iridocorneal contact but no angle structures
can be identified.
Grade 0 (0°) is closed due to iridocorneal contact.
Classification of the Glaucomas
• Open angle
• Angle closure
• Primary
• Secondary
Open-angle glaucomas
Primary open-
angle glaucoma
(POAG)
Not associated with known ocular or systemic
disorders that cause increased resistance to
aqueous outflow or damage to optic nerve;
usually associated with elevated I O P
Normal-tension
glaucoma ( NTG)
Considered in continuum of POAG;
terminology often used when I O P is not
elevated
Juvenile open-
angle
glaucoma (JOAG)
Terminology often used when open-angle
glaucoma diagnosed at young age (typically 4-
35 years of age)
Ocular
hypertension
Normal optic disc and visual field associated
with elevated I O P
Glaucoma suspect Suspicious optic disc or visual field regardless
of I O P
Secondary open
angle
glaucoma
Increased resistance to trabecular meshwork
outflow associated with other conditions (eg,
pigmentary glaucoma, phaco-lytic glaucoma,
steroid-induced glaucoma, exfoliation
syndrome, angle-recession
glaucoma)
Increased post-trabecular resistance to
outflow secondary to elevated
episcleral venous pressure (eg, carotid
cavernous sinus fistula)
POAG
DEFINITION
IOP > 21 mmHg Open angle of normal appearance
Visual field lossGlaucomatous disc damage
RISK FACTORS
• Genetics- multifactorial & polygenic – long arm of
chromosome 1
• Age : 6th-7th decade , rare before 40 yrs of age
• Sex : Both sexes equally affected
• Race: Blacks > Whites
• Family history: siblings 10% risk, offspring-4 %
• Diabetes mellitus
• Ocular associations
– Myopia ,CRVO, RRD, RP
• ↑ steroid responsiveness
Pathogenesis
Direct damage by pressure Ischemia
Interference with
axoplasmic flow
SYMPTOMS
• Insidious Onset/Nonspecific
• ‘Asymptomatic’ most of the time
• Painless Progressive Loss of Vision
• Dull Headache / eye pain
• Difficulty in Near Work
• Constant pressure on ciliary muscle
• Frequent change in presbyopic correction
• Difficulty in vision more at night (dark adaptation
delay )
• Dark areas (scotomas) in field of vision
Diagnosis
CLASSICAL TRIAD
• RAISED IOP
• OPTIC NERVE HEAD CUPPING
• VISUAL FIELD DEFECTS
• On Gonioscopy - the angle should be ‘normal’
and ‘open’
Management
Principle:
• Determine TARGET PRESSURE - the range of
IOP at which there is no further progression of
glaucomatous damage.
• Parameters to document:
• Baseline IOP at which damage occurred
• Extent/severity of damage
• Associated risk factors
Treatment
• Medical
• LASER
• Surgery
MEDICAL
 MECHANISM
• Decreased aqueous production
• Increased facility of outflow (trabecular / uveoscleral)
• Intraocular osmotic fluid reduction
LASER THERAPY
Argon laser trabeculoplasty
Selective laser trabeculoplasty
Surgical
TRABECULECTOMY
• Involves creation of
fistula between angle of
anterior chamber and
sub Tenon’s space
NORMAL TENSION GLAUCOMA
• Definition:
– Typical glaucomatous optic disc cupping
– Visual field loss
– A mean IOP ≤ 21mm of Hg on diurnal testing
– Open angles
– Absence of any contributing ocular / specific
systemic disorders
EPIDEMIOLOGY
• NTG accounts for 30% of the Glaucomas
• Age – significantly older than POAG
• Gender – females ≥ males – 2:1
• Race – Japan
• Family history – POAG is greater in families
of patients of NTG
PATHOGENESIS
• Controversy
• Vascular insufficiency
• Decreased optic disc resistance
• Optic nerve compression by normal carotid
arteries
CLINICAL FEATURES
• IOP
• In high teens
• Wide diurnal and postural IOP fluctuations
• Night and early morning spikes
• Visual field changes
• Closer to fixation
• Deeper
• Steeper
• Localised
CLINICAL FEATURES
• Splinter hemorrhage
• Acquired optic disc pits
• Focal notching
CLINICAL FEATURES
• OTHERS
• Peripheral vasospasm on cooling
• Migraine
• Nocturnal hypotension
• Reduced blood flow in ophthalmic & posterior ciliary
arteries
• Paraprotienaemias and presence of serum auto
antibodies
TREATMENT OF NTG
• Lower IOP by 30%
• Betaxolol- Increases the pulsatile ocular blood flow to the
optic nerve
• Brimonidine 0.2%:Neuroprotective
• Prostaglandin analogues –
• Latanoprost: 0.005% once daily
• Bimatoprost: 0.03%
• Travoprost: 0.004%
• Dorzolamide
• Improves blood flow and velocity in the vicinity of optic nerve
• Calcium channel Blockers
OCULAR HYPERTENSION
• Definition:
– IOP 22mm of Hg or greater
– Normal optic disc
– Normal Visual Fields
– Open angle
– Absence of any ocular or systemic disorder
contributing to elevated IOP
RISK FACTORS
• Increasing age
• Retinal nerve fibre layer defects
• Optic nerve head morphology
– Higher vertical C/D ratio
• Elevated IOP
• Peripapillary changes
• Central corneal thickness
• Positive family history -first degree relative
• High Myopia
MANAGEMENT
• 20% IOP reduction
• Medical
Other modalities less frequently
• LASER
• Surgery
• POAG clinical features
• ONH changes in POAG
• Visual field defects in POAG
• Management

Más contenido relacionado

La actualidad más candente

Pathological Myopia.pptx
Pathological Myopia.pptxPathological Myopia.pptx
Pathological Myopia.pptxMohammad Bawtag
 
Hypertension and ocular changes
Hypertension and ocular changesHypertension and ocular changes
Hypertension and ocular changesAbdul Rahim Shaan
 
Corneal dystrophies
Corneal dystrophiesCorneal dystrophies
Corneal dystrophiesNajara Thapa
 
non paralytic and paralytic strabismus- 20.07.16
 non paralytic and paralytic strabismus- 20.07.16 non paralytic and paralytic strabismus- 20.07.16
non paralytic and paralytic strabismus- 20.07.16ophthalmgmcri
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive RetinopathySanasaleem2
 
Primary open angle glaucoma (poag)kalpy
Primary open angle glaucoma (poag)kalpyPrimary open angle glaucoma (poag)kalpy
Primary open angle glaucoma (poag)kalpykalpana sangwan
 
Central retinal vein occlusion CRVO
Central retinal vein occlusion CRVOCentral retinal vein occlusion CRVO
Central retinal vein occlusion CRVODr. Md. Suzon Islam
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
Hypertensive retinopathyAngel Das
 
Intermediate uveitis
Intermediate uveitisIntermediate uveitis
Intermediate uveitisBarun Garg
 
Diabetic macular edema
Diabetic macular edemaDiabetic macular edema
Diabetic macular edemadrkvasantha
 
Biometry: Iol calculation
Biometry: Iol calculation Biometry: Iol calculation
Biometry: Iol calculation Noor Munirah Aab
 
History taking in ophthalmology
History taking in ophthalmologyHistory taking in ophthalmology
History taking in ophthalmologyRavoori Anudeep
 
HYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptxHYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptxBipin Koirala
 
Congenital Glaucoma
Congenital GlaucomaCongenital Glaucoma
Congenital GlaucomaSahil Thakur
 

La actualidad más candente (20)

Pathological Myopia.pptx
Pathological Myopia.pptxPathological Myopia.pptx
Pathological Myopia.pptx
 
Hypertension and ocular changes
Hypertension and ocular changesHypertension and ocular changes
Hypertension and ocular changes
 
Lens induced glaucoma.
Lens induced glaucoma.Lens induced glaucoma.
Lens induced glaucoma.
 
Corneal dystrophies
Corneal dystrophiesCorneal dystrophies
Corneal dystrophies
 
non paralytic and paralytic strabismus- 20.07.16
 non paralytic and paralytic strabismus- 20.07.16 non paralytic and paralytic strabismus- 20.07.16
non paralytic and paralytic strabismus- 20.07.16
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive Retinopathy
 
Primary open angle glaucoma (poag)kalpy
Primary open angle glaucoma (poag)kalpyPrimary open angle glaucoma (poag)kalpy
Primary open angle glaucoma (poag)kalpy
 
Bruckner test
Bruckner testBruckner test
Bruckner test
 
Corneal Dystrophies
Corneal DystrophiesCorneal Dystrophies
Corneal Dystrophies
 
Central retinal vein occlusion CRVO
Central retinal vein occlusion CRVOCentral retinal vein occlusion CRVO
Central retinal vein occlusion CRVO
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
Hypertensive retinopathy
 
Intermediate uveitis
Intermediate uveitisIntermediate uveitis
Intermediate uveitis
 
Cystoid macular oedema
Cystoid macular oedemaCystoid macular oedema
Cystoid macular oedema
 
Esotropia
EsotropiaEsotropia
Esotropia
 
Diabetic macular edema
Diabetic macular edemaDiabetic macular edema
Diabetic macular edema
 
Biometry: Iol calculation
Biometry: Iol calculation Biometry: Iol calculation
Biometry: Iol calculation
 
Macular function tests
Macular function testsMacular function tests
Macular function tests
 
History taking in ophthalmology
History taking in ophthalmologyHistory taking in ophthalmology
History taking in ophthalmology
 
HYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptxHYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptx
 
Congenital Glaucoma
Congenital GlaucomaCongenital Glaucoma
Congenital Glaucoma
 

Destacado

Primary open angle glaucoma (poag)
Primary open angle glaucoma (poag)Primary open angle glaucoma (poag)
Primary open angle glaucoma (poag)Om Patel
 
Primary open angle glaucoma
Primary open angle glaucomaPrimary open angle glaucoma
Primary open angle glaucomaketan bhardwaj
 
Primary open angle glaucoma
Primary open angle glaucomaPrimary open angle glaucoma
Primary open angle glaucomaSampda Sharma
 
Glaucoma 3 primary open angle glaucoma,dr.k.n.jha, 03.11.16
Glaucoma 3 primary open angle glaucoma,dr.k.n.jha, 03.11.16Glaucoma 3 primary open angle glaucoma,dr.k.n.jha, 03.11.16
Glaucoma 3 primary open angle glaucoma,dr.k.n.jha, 03.11.16ophthalmgmcri
 
Glaucoma
GlaucomaGlaucoma
GlaucomaGoogle
 
Case control studies
Case control studiesCase control studies
Case control studiesBruno Mmassy
 
Diagnosis of glaucoma
Diagnosis of glaucomaDiagnosis of glaucoma
Diagnosis of glaucomaSue Ting Lim
 
Bacterial corneal ulcer (pathogenesis, pathology, clinical features).
Bacterial corneal ulcer (pathogenesis, pathology, clinical features).Bacterial corneal ulcer (pathogenesis, pathology, clinical features).
Bacterial corneal ulcer (pathogenesis, pathology, clinical features).AyeshaBintSarwar
 
Surgical Anatomy Of The Nose
Surgical Anatomy Of The NoseSurgical Anatomy Of The Nose
Surgical Anatomy Of The NoseChih-Yen Wei
 
Surgical management of glaucoma pgs
Surgical management of glaucoma   pgsSurgical management of glaucoma   pgs
Surgical management of glaucoma pgsdocsarsi
 
Primary angle closure glaucoma
Primary angle closure glaucomaPrimary angle closure glaucoma
Primary angle closure glaucomaMutahir Shah
 
Case Control Studies
Case Control StudiesCase Control Studies
Case Control StudiesRachel Walden
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort studyBhumika Bhatt
 
Optic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaOptic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaDr Laltanpuia Chhangte
 
Antifungal Agents in Ophthalmology
Antifungal Agents in OphthalmologyAntifungal Agents in Ophthalmology
Antifungal Agents in OphthalmologyAnkit Punjabi
 

Destacado (20)

Primary open angle glaucoma (poag)
Primary open angle glaucoma (poag)Primary open angle glaucoma (poag)
Primary open angle glaucoma (poag)
 
Primary open angle glaucoma
Primary open angle glaucomaPrimary open angle glaucoma
Primary open angle glaucoma
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Primary open angle glaucoma
Primary open angle glaucomaPrimary open angle glaucoma
Primary open angle glaucoma
 
POAG
POAGPOAG
POAG
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Glaucoma 3 primary open angle glaucoma,dr.k.n.jha, 03.11.16
Glaucoma 3 primary open angle glaucoma,dr.k.n.jha, 03.11.16Glaucoma 3 primary open angle glaucoma,dr.k.n.jha, 03.11.16
Glaucoma 3 primary open angle glaucoma,dr.k.n.jha, 03.11.16
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Case control studies
Case control studiesCase control studies
Case control studies
 
Diagnosis of glaucoma
Diagnosis of glaucomaDiagnosis of glaucoma
Diagnosis of glaucoma
 
Bacterial corneal ulcer (pathogenesis, pathology, clinical features).
Bacterial corneal ulcer (pathogenesis, pathology, clinical features).Bacterial corneal ulcer (pathogenesis, pathology, clinical features).
Bacterial corneal ulcer (pathogenesis, pathology, clinical features).
 
Surgical Anatomy Of The Nose
Surgical Anatomy Of The NoseSurgical Anatomy Of The Nose
Surgical Anatomy Of The Nose
 
Primary Glaucoma
Primary GlaucomaPrimary Glaucoma
Primary Glaucoma
 
Surgical management of glaucoma pgs
Surgical management of glaucoma   pgsSurgical management of glaucoma   pgs
Surgical management of glaucoma pgs
 
Primary angle closure glaucoma
Primary angle closure glaucomaPrimary angle closure glaucoma
Primary angle closure glaucoma
 
Case Control Studies
Case Control StudiesCase Control Studies
Case Control Studies
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort study
 
Optic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaOptic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucoma
 
Cornea
CorneaCornea
Cornea
 
Antifungal Agents in Ophthalmology
Antifungal Agents in OphthalmologyAntifungal Agents in Ophthalmology
Antifungal Agents in Ophthalmology
 

Similar a Poag 28.04.16 - dr.a.r.rajalakshmi

Similar a Poag 28.04.16 - dr.a.r.rajalakshmi (20)

POAG AND PACG
POAG AND PACGPOAG AND PACG
POAG AND PACG
 
Primary Angle Closure Glaucoma- Saral
Primary Angle Closure Glaucoma- SaralPrimary Angle Closure Glaucoma- Saral
Primary Angle Closure Glaucoma- Saral
 
Gradual vision loss
Gradual vision lossGradual vision loss
Gradual vision loss
 
Glaucoma ppt kiran oli
Glaucoma ppt kiran oliGlaucoma ppt kiran oli
Glaucoma ppt kiran oli
 
Glaucoma RCSI
Glaucoma RCSIGlaucoma RCSI
Glaucoma RCSI
 
Glaucoma diska
Glaucoma diskaGlaucoma diska
Glaucoma diska
 
VF in glaucoma.pptx
VF in glaucoma.pptxVF in glaucoma.pptx
VF in glaucoma.pptx
 
Glaucoma dr.eqbal
Glaucoma  dr.eqbalGlaucoma  dr.eqbal
Glaucoma dr.eqbal
 
14. Primary glaucoma.pptx
14. Primary glaucoma.pptx14. Primary glaucoma.pptx
14. Primary glaucoma.pptx
 
14. Primary glaucoma.pptx
14. Primary glaucoma.pptx14. Primary glaucoma.pptx
14. Primary glaucoma.pptx
 
Glaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptxGlaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptx
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
POAG.pptx
POAG.pptxPOAG.pptx
POAG.pptx
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Glaucoma (opthalmology)
Glaucoma (opthalmology)Glaucoma (opthalmology)
Glaucoma (opthalmology)
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Acg
AcgAcg
Acg
 
POAG by junaid afsar.pptx
POAG by junaid afsar.pptxPOAG by junaid afsar.pptx
POAG by junaid afsar.pptx
 
PRIMARY OPEN ANGLE GLAUCOMA - Copy (2).pptx
PRIMARY OPEN ANGLE GLAUCOMA - Copy (2).pptxPRIMARY OPEN ANGLE GLAUCOMA - Copy (2).pptx
PRIMARY OPEN ANGLE GLAUCOMA - Copy (2).pptx
 

Más de ophthalmgmcri

Csom aa, 10.04.17, s.s.bakshi
Csom aa, 10.04.17,  s.s.bakshiCsom aa, 10.04.17,  s.s.bakshi
Csom aa, 10.04.17, s.s.bakshiophthalmgmcri
 
Csom.dr.bini,03.04.17
Csom.dr.bini,03.04.17Csom.dr.bini,03.04.17
Csom.dr.bini,03.04.17ophthalmgmcri
 
Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm, 20.03.17
Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm,   20.03.17Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm,   20.03.17
Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm, 20.03.17ophthalmgmcri
 
Lens iii 13.04.17 - dr.n.swathi
Lens iii 13.04.17 - dr.n.swathiLens iii 13.04.17 - dr.n.swathi
Lens iii 13.04.17 - dr.n.swathiophthalmgmcri
 
Lens ii 12.04.17,n.swathi.n
Lens ii 12.04.17,n.swathi.nLens ii 12.04.17,n.swathi.n
Lens ii 12.04.17,n.swathi.nophthalmgmcri
 
Lens i 06.04.17,dr.n.swathi
Lens i 06.04.17,dr.n.swathiLens i 06.04.17,dr.n.swathi
Lens i 06.04.17,dr.n.swathiophthalmgmcri
 
Ocular pharmacology ii, dr.kurinchi, 22.06.17
Ocular pharmacology ii, dr.kurinchi, 22.06.17Ocular pharmacology ii, dr.kurinchi, 22.06.17
Ocular pharmacology ii, dr.kurinchi, 22.06.17ophthalmgmcri
 
Ocular pharmacology i,dr.kuricnchi,16.03.17
Ocular pharmacology i,dr.kuricnchi,16.03.17Ocular pharmacology i,dr.kuricnchi,16.03.17
Ocular pharmacology i,dr.kuricnchi,16.03.17ophthalmgmcri
 
Dr.A.R.Rajalakshmi, 8.2.17 chronic conjunctivitis ii
Dr.A.R.Rajalakshmi,  8.2.17 chronic conjunctivitis iiDr.A.R.Rajalakshmi,  8.2.17 chronic conjunctivitis ii
Dr.A.R.Rajalakshmi, 8.2.17 chronic conjunctivitis iiophthalmgmcri
 
Dr.A.R.Rajalakshmi, 02.2.17 intro, acute conj - i
Dr.A.R.Rajalakshmi, 02.2.17   intro, acute conj  - iDr.A.R.Rajalakshmi, 02.2.17   intro, acute conj  - i
Dr.A.R.Rajalakshmi, 02.2.17 intro, acute conj - iophthalmgmcri
 
Dr.r.subramaniyan, 09 3-17,Aqueous Humour Dynamics
Dr.r.subramaniyan, 09 3-17,Aqueous Humour DynamicsDr.r.subramaniyan, 09 3-17,Aqueous Humour Dynamics
Dr.r.subramaniyan, 09 3-17,Aqueous Humour Dynamicsophthalmgmcri
 
Dr. r.subramaniyan, 08 3-17 tear film
Dr. r.subramaniyan, 08 3-17 tear filmDr. r.subramaniyan, 08 3-17 tear film
Dr. r.subramaniyan, 08 3-17 tear filmophthalmgmcri
 
Disease of middle ear,dr.s.s.bakshi,27.03.17
Disease of middle ear,dr.s.s.bakshi,27.03.17Disease of middle ear,dr.s.s.bakshi,27.03.17
Disease of middle ear,dr.s.s.bakshi,27.03.17ophthalmgmcri
 
Diseases of external ear,dr.s.gopalakrishnan, 13.03.17
Diseases of external ear,dr.s.gopalakrishnan, 13.03.17Diseases of external ear,dr.s.gopalakrishnan, 13.03.17
Diseases of external ear,dr.s.gopalakrishnan, 13.03.17ophthalmgmcri
 
Dis of mid ear,dr.s.s.bakshi,27.03.17
Dis of mid ear,dr.s.s.bakshi,27.03.17Dis of mid ear,dr.s.s.bakshi,27.03.17
Dis of mid ear,dr.s.s.bakshi,27.03.17ophthalmgmcri
 
Diseases of external ear,dr.s.gopalakrishnan, 13.06.17
Diseases of external ear,dr.s.gopalakrishnan, 13.06.17Diseases of external ear,dr.s.gopalakrishnan, 13.06.17
Diseases of external ear,dr.s.gopalakrishnan, 13.06.17ophthalmgmcri
 
Dr. reema thomas aqueous dynamics 18 1-17
Dr. reema thomas aqueous dynamics 18 1-17Dr. reema thomas aqueous dynamics 18 1-17
Dr. reema thomas aqueous dynamics 18 1-17ophthalmgmcri
 

Más de ophthalmgmcri (20)

Csom aa, 10.04.17, s.s.bakshi
Csom aa, 10.04.17,  s.s.bakshiCsom aa, 10.04.17,  s.s.bakshi
Csom aa, 10.04.17, s.s.bakshi
 
Csom.dr.bini,03.04.17
Csom.dr.bini,03.04.17Csom.dr.bini,03.04.17
Csom.dr.bini,03.04.17
 
Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm, 20.03.17
Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm,   20.03.17Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm,   20.03.17
Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm, 20.03.17
 
Lens iii 13.04.17 - dr.n.swathi
Lens iii 13.04.17 - dr.n.swathiLens iii 13.04.17 - dr.n.swathi
Lens iii 13.04.17 - dr.n.swathi
 
Lens ii 12.04.17,n.swathi.n
Lens ii 12.04.17,n.swathi.nLens ii 12.04.17,n.swathi.n
Lens ii 12.04.17,n.swathi.n
 
Lens i 06.04.17,dr.n.swathi
Lens i 06.04.17,dr.n.swathiLens i 06.04.17,dr.n.swathi
Lens i 06.04.17,dr.n.swathi
 
Uvea 3,22.03.17
Uvea 3,22.03.17Uvea 3,22.03.17
Uvea 3,22.03.17
 
Uvea 2,16.03.17
Uvea 2,16.03.17Uvea 2,16.03.17
Uvea 2,16.03.17
 
Uvea 1,15.03.17
Uvea 1,15.03.17Uvea 1,15.03.17
Uvea 1,15.03.17
 
Ocular pharmacology ii, dr.kurinchi, 22.06.17
Ocular pharmacology ii, dr.kurinchi, 22.06.17Ocular pharmacology ii, dr.kurinchi, 22.06.17
Ocular pharmacology ii, dr.kurinchi, 22.06.17
 
Ocular pharmacology i,dr.kuricnchi,16.03.17
Ocular pharmacology i,dr.kuricnchi,16.03.17Ocular pharmacology i,dr.kuricnchi,16.03.17
Ocular pharmacology i,dr.kuricnchi,16.03.17
 
Dr.A.R.Rajalakshmi, 8.2.17 chronic conjunctivitis ii
Dr.A.R.Rajalakshmi,  8.2.17 chronic conjunctivitis iiDr.A.R.Rajalakshmi,  8.2.17 chronic conjunctivitis ii
Dr.A.R.Rajalakshmi, 8.2.17 chronic conjunctivitis ii
 
Dr.A.R.Rajalakshmi, 02.2.17 intro, acute conj - i
Dr.A.R.Rajalakshmi, 02.2.17   intro, acute conj  - iDr.A.R.Rajalakshmi, 02.2.17   intro, acute conj  - i
Dr.A.R.Rajalakshmi, 02.2.17 intro, acute conj - i
 
Dr.r.subramaniyan, 09 3-17,Aqueous Humour Dynamics
Dr.r.subramaniyan, 09 3-17,Aqueous Humour DynamicsDr.r.subramaniyan, 09 3-17,Aqueous Humour Dynamics
Dr.r.subramaniyan, 09 3-17,Aqueous Humour Dynamics
 
Dr. r.subramaniyan, 08 3-17 tear film
Dr. r.subramaniyan, 08 3-17 tear filmDr. r.subramaniyan, 08 3-17 tear film
Dr. r.subramaniyan, 08 3-17 tear film
 
Disease of middle ear,dr.s.s.bakshi,27.03.17
Disease of middle ear,dr.s.s.bakshi,27.03.17Disease of middle ear,dr.s.s.bakshi,27.03.17
Disease of middle ear,dr.s.s.bakshi,27.03.17
 
Diseases of external ear,dr.s.gopalakrishnan, 13.03.17
Diseases of external ear,dr.s.gopalakrishnan, 13.03.17Diseases of external ear,dr.s.gopalakrishnan, 13.03.17
Diseases of external ear,dr.s.gopalakrishnan, 13.03.17
 
Dis of mid ear,dr.s.s.bakshi,27.03.17
Dis of mid ear,dr.s.s.bakshi,27.03.17Dis of mid ear,dr.s.s.bakshi,27.03.17
Dis of mid ear,dr.s.s.bakshi,27.03.17
 
Diseases of external ear,dr.s.gopalakrishnan, 13.06.17
Diseases of external ear,dr.s.gopalakrishnan, 13.06.17Diseases of external ear,dr.s.gopalakrishnan, 13.06.17
Diseases of external ear,dr.s.gopalakrishnan, 13.06.17
 
Dr. reema thomas aqueous dynamics 18 1-17
Dr. reema thomas aqueous dynamics 18 1-17Dr. reema thomas aqueous dynamics 18 1-17
Dr. reema thomas aqueous dynamics 18 1-17
 

Último

AI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of DataAI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of DataIris Thiele Isip-Tan
 
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE  STUDY ON CHRONIC KIDNEY DISEASE.pptxCASE  STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptxdrsriram2001
 
Sustainable Living Practices For Better Health.pptx
Sustainable Living Practices For Better Health.pptxSustainable Living Practices For Better Health.pptx
Sustainable Living Practices For Better Health.pptxHealth 2Conf
 
Professional Ear Wax Cleaning Services for Your Home
Professional Ear Wax Cleaning Services for Your HomeProfessional Ear Wax Cleaning Services for Your Home
Professional Ear Wax Cleaning Services for Your HomeEarwax Doctor
 
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are HeardAdvance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are HeardVITASAuthor
 
Discover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalDiscover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalA-dec Australia
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationpratiksha ghimire
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
EHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinEHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinJasper Colin
 
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfeurohealthleaders
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 
Staying Safe in Hospitals: Fire Safety Guidelines for Hospitals in India
Staying Safe in Hospitals: Fire Safety Guidelines for Hospitals in IndiaStaying Safe in Hospitals: Fire Safety Guidelines for Hospitals in India
Staying Safe in Hospitals: Fire Safety Guidelines for Hospitals in IndiaBasic Elements
 
Mental Health for physiotherapy and other health students
Mental Health for physiotherapy and other health studentsMental Health for physiotherapy and other health students
Mental Health for physiotherapy and other health studentseyobkaseye
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfDharma Homoeopathy
 
Latest Dr Ranjit Jagtap News In Healthcare Field
Latest Dr Ranjit Jagtap News In Healthcare  FieldLatest Dr Ranjit Jagtap News In Healthcare  Field
Latest Dr Ranjit Jagtap News In Healthcare FieldDr Ranjit Jagtap
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginessbkling
 
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfPreventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfAditiAlishetty
 
20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health SupportSayhey
 
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...The Lifesciences Magazine
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...mauryashreya478
 

Último (20)

AI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of DataAI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of Data
 
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE  STUDY ON CHRONIC KIDNEY DISEASE.pptxCASE  STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
 
Sustainable Living Practices For Better Health.pptx
Sustainable Living Practices For Better Health.pptxSustainable Living Practices For Better Health.pptx
Sustainable Living Practices For Better Health.pptx
 
Professional Ear Wax Cleaning Services for Your Home
Professional Ear Wax Cleaning Services for Your HomeProfessional Ear Wax Cleaning Services for Your Home
Professional Ear Wax Cleaning Services for Your Home
 
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are HeardAdvance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
 
Discover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalDiscover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa Dental
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentation
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
EHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinEHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper Colin
 
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 
Staying Safe in Hospitals: Fire Safety Guidelines for Hospitals in India
Staying Safe in Hospitals: Fire Safety Guidelines for Hospitals in IndiaStaying Safe in Hospitals: Fire Safety Guidelines for Hospitals in India
Staying Safe in Hospitals: Fire Safety Guidelines for Hospitals in India
 
Mental Health for physiotherapy and other health students
Mental Health for physiotherapy and other health studentsMental Health for physiotherapy and other health students
Mental Health for physiotherapy and other health students
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
 
Latest Dr Ranjit Jagtap News In Healthcare Field
Latest Dr Ranjit Jagtap News In Healthcare  FieldLatest Dr Ranjit Jagtap News In Healthcare  Field
Latest Dr Ranjit Jagtap News In Healthcare Field
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginess
 
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfPreventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
 
20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support
 
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...
 

Poag 28.04.16 - dr.a.r.rajalakshmi

  • 1. Primary Open angle Glaucoma Dr. AR Rajalakshmi
  • 2. • Glaucoma – Overview • POAG clinical features • Management
  • 3. DEFINITION • Glaucoma is a chronic, progressive optic neuropathy caused by a group of ocular conditions which lead to damage of the optic nerve with loss of visual function. • The most common risk factor known is a raised intraocular pressure.
  • 4.
  • 5. PATHOGENESIS • MECHANICAL changes due to the rise of intraocular pressure and • VASCULAR perfusion of the optic nerve head.
  • 6. MECHANICAL mechanical pressure on the lamina cribrosa mechanical pressure on the lamina cribrosa altering capillary blood flow backward displacement and compaction of the laminar plates narrows the openings through which the axons pass GANGLION CELL DEATH
  • 7. VASCULAR rise in intraocular pressure mechanical pressure on the lamina cribrosa decrease the capillary blood flow mechanical compression of vessels at the lamina cribrosa GANGLION CELL DEATH
  • 8.
  • 9. Diagnosis combination of clinical signs—characteristic changes in • the optic nerve head • abnormalities in the visual field • rise in intraocular pressure • The type of glaucoma is determined by the status of the anterior chamber angle as determined by gonioscopy
  • 10. Optic nerve head changes
  • 11. OPTIC NERVE HEAD – EARLY SIGNS Increase in vertical c:d > 0.5 Asymmetry between the two optic nerve heads of more than 0.2
  • 13. OPTIC NERVE HEAD – LATE CHANGES MARKED CUPPING POLAR NOTCHING Nasalisation of vessels
  • 14. Peripapillary changes Loss of NRR & disc pallor
  • 15. VISUAL FIELD • Portion of space in which objects are simultaneously visible to the steadily fixating eye.
  • 16. Visual field examination Screening tests … • Confrontational visual field testing • Amsler grid (assesses the central 10° the visual field ) . Quantitative measurements using manual or automated perimetry
  • 17. DISTRIBUTION OF RETINAL NERVE FIBRES BJERRUM’S AREA : an arcuate area extending above and below the blind spot , 10 to 25 ̊ from fixation
  • 18. Visual field defects • Relative paracentral scotoma • Roenne’s nasal step • Seidel scotoma • Arcuate scotoma • Double arcuate / ring scotoma • End stage / near total field defect
  • 19. • RELATIVE PARACENTRAL SCOTOMA – areas where smaller / dimmer objects are not visualised by patient but larger & brighter objects are seen • SEIDEL SCOTOMA • starts at the poles of the blind spot , arches over the macular area without reaching the horizontal meridian nasally
  • 20. ARCUATE SCOTOMA • Starts at superior or inferior poles of blind spot • Arches over macular area • Ends as a horizontal line nasally • Does not cross the horizontal divide of visual field DOUBLE ARCUATE / RING SCOTOMA • Two arcuate scotomas expand to involve the peripheral visual field • Central(tubular vision ) and temporal islands of vision are left
  • 21. ROENNE’S NASAL STEP • Appearance of a horizontal shelf in the nasal visual field. • Caused by asymmetrical nerve fibre loss at the poles END STAGE / NEAR TOTAL FIELD DEFECT • Small island of temporal vision
  • 22. Intraocular pressure • IOP > 21mmHg on more than one occasion • Circadian Variation > 8mmHg • Asymmetry in IOP between 2 eyes of more than 5 mmHg
  • 23. GAT
  • 24. Different types of tonometers
  • 26. Grading of angles van Herick Shaffer system Spaeth Scheie
  • 27. Schaffer’s grading Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Grade 4 (35–45°) is the widest angle, the ciliary body can be visualized. Grade 3 (25–35°) is an open angle, scleral spur is visible. Grade 2 (20°) is an angle in which the trabeculum but not the scleral spur can be seen. Grade 1 (10°) is a very narrow angle in which only the Schwalbe line and perhaps the top of the trabeculum can be identified. Slit angle is one in which there is no obvious iridocorneal contact but no angle structures can be identified. Grade 0 (0°) is closed due to iridocorneal contact.
  • 28. Classification of the Glaucomas • Open angle • Angle closure • Primary • Secondary
  • 29. Open-angle glaucomas Primary open- angle glaucoma (POAG) Not associated with known ocular or systemic disorders that cause increased resistance to aqueous outflow or damage to optic nerve; usually associated with elevated I O P Normal-tension glaucoma ( NTG) Considered in continuum of POAG; terminology often used when I O P is not elevated Juvenile open- angle glaucoma (JOAG) Terminology often used when open-angle glaucoma diagnosed at young age (typically 4- 35 years of age)
  • 30. Ocular hypertension Normal optic disc and visual field associated with elevated I O P Glaucoma suspect Suspicious optic disc or visual field regardless of I O P Secondary open angle glaucoma Increased resistance to trabecular meshwork outflow associated with other conditions (eg, pigmentary glaucoma, phaco-lytic glaucoma, steroid-induced glaucoma, exfoliation syndrome, angle-recession glaucoma) Increased post-trabecular resistance to outflow secondary to elevated episcleral venous pressure (eg, carotid cavernous sinus fistula)
  • 31. POAG
  • 32. DEFINITION IOP > 21 mmHg Open angle of normal appearance Visual field lossGlaucomatous disc damage
  • 33. RISK FACTORS • Genetics- multifactorial & polygenic – long arm of chromosome 1 • Age : 6th-7th decade , rare before 40 yrs of age • Sex : Both sexes equally affected • Race: Blacks > Whites • Family history: siblings 10% risk, offspring-4 % • Diabetes mellitus • Ocular associations – Myopia ,CRVO, RRD, RP • ↑ steroid responsiveness
  • 34. Pathogenesis Direct damage by pressure Ischemia Interference with axoplasmic flow
  • 35. SYMPTOMS • Insidious Onset/Nonspecific • ‘Asymptomatic’ most of the time • Painless Progressive Loss of Vision • Dull Headache / eye pain • Difficulty in Near Work • Constant pressure on ciliary muscle • Frequent change in presbyopic correction • Difficulty in vision more at night (dark adaptation delay ) • Dark areas (scotomas) in field of vision
  • 36. Diagnosis CLASSICAL TRIAD • RAISED IOP • OPTIC NERVE HEAD CUPPING • VISUAL FIELD DEFECTS • On Gonioscopy - the angle should be ‘normal’ and ‘open’
  • 37. Management Principle: • Determine TARGET PRESSURE - the range of IOP at which there is no further progression of glaucomatous damage. • Parameters to document: • Baseline IOP at which damage occurred • Extent/severity of damage • Associated risk factors
  • 39. MEDICAL  MECHANISM • Decreased aqueous production • Increased facility of outflow (trabecular / uveoscleral) • Intraocular osmotic fluid reduction
  • 40. LASER THERAPY Argon laser trabeculoplasty Selective laser trabeculoplasty
  • 41. Surgical TRABECULECTOMY • Involves creation of fistula between angle of anterior chamber and sub Tenon’s space
  • 42. NORMAL TENSION GLAUCOMA • Definition: – Typical glaucomatous optic disc cupping – Visual field loss – A mean IOP ≤ 21mm of Hg on diurnal testing – Open angles – Absence of any contributing ocular / specific systemic disorders
  • 43. EPIDEMIOLOGY • NTG accounts for 30% of the Glaucomas • Age – significantly older than POAG • Gender – females ≥ males – 2:1 • Race – Japan • Family history – POAG is greater in families of patients of NTG
  • 44. PATHOGENESIS • Controversy • Vascular insufficiency • Decreased optic disc resistance • Optic nerve compression by normal carotid arteries
  • 45. CLINICAL FEATURES • IOP • In high teens • Wide diurnal and postural IOP fluctuations • Night and early morning spikes • Visual field changes • Closer to fixation • Deeper • Steeper • Localised
  • 46. CLINICAL FEATURES • Splinter hemorrhage • Acquired optic disc pits • Focal notching
  • 47. CLINICAL FEATURES • OTHERS • Peripheral vasospasm on cooling • Migraine • Nocturnal hypotension • Reduced blood flow in ophthalmic & posterior ciliary arteries • Paraprotienaemias and presence of serum auto antibodies
  • 48. TREATMENT OF NTG • Lower IOP by 30% • Betaxolol- Increases the pulsatile ocular blood flow to the optic nerve • Brimonidine 0.2%:Neuroprotective • Prostaglandin analogues – • Latanoprost: 0.005% once daily • Bimatoprost: 0.03% • Travoprost: 0.004% • Dorzolamide • Improves blood flow and velocity in the vicinity of optic nerve • Calcium channel Blockers
  • 49. OCULAR HYPERTENSION • Definition: – IOP 22mm of Hg or greater – Normal optic disc – Normal Visual Fields – Open angle – Absence of any ocular or systemic disorder contributing to elevated IOP
  • 50. RISK FACTORS • Increasing age • Retinal nerve fibre layer defects • Optic nerve head morphology – Higher vertical C/D ratio • Elevated IOP • Peripapillary changes • Central corneal thickness • Positive family history -first degree relative • High Myopia
  • 51. MANAGEMENT • 20% IOP reduction • Medical Other modalities less frequently • LASER • Surgery
  • 52. • POAG clinical features • ONH changes in POAG • Visual field defects in POAG • Management

Notas del editor

  1. non selective Beta blockers are not used